https://www.exscientia.ai | United Kingdom | 2012 | $673.7M
Exscientia is an AI-driven drug discovery and design company based in the United Kingdom. The company aims to use artificial intelligence to discover and design better quality drugs more efficiently. Exscientia has developed proprietary AI-powered platforms and methodologies to accelerate the identification, design, and testing of new drug candidates. The company has received funding from various investors, including the BBSRC and Evotec, and went public on the Nasdaq in 2021. Exscientia has also formed partnerships with other pharmaceutical and biotech companies to advance its AI-based drug discovery efforts.
